Why the study?
Does double filtration plasmapheresis (DFPP) improve quality of life and reduce inflammation in male patients with borderline hyper-LDL-cholesterolemia?
Does double filtration plasmapheresis (DFPP) improve quality of life and reduce inflammation in male patients with borderline hyper-LDL-cholesterolemia?
Double filtration plasmapheresis may suppress inflammation and improve certain quality of life symptoms in men with borderline hyper-LDL-cholesterolemia, despite an unexpected increase in LDL-C levels.
DFPP-associated hs-CRP reduction despite higher LDL-C should not change practice; hypothesis-generating for anti-inflammatory effects, needing RCTs.
Objective: Double filtration plasmapheresis (DFPP) removal of LDL cholesterol (LDL-C) and other pathogenic substances in the blood has attracted attention as an effective treatment of arteriosclerotic lesions. We conducted a controlled open-label study to understand the physical and mental effects of DFPP.Methods: Seven (7) male patients with borderline hyper-LDL-C (134.0±41.1 mg/dL) were assigned to a DFPP group (age 43.0±5.3 years, BMI 26.0±4.5) and 7 others were assigned to a control group (age 39.1±11.4 years, BMI 28.9±8.1). The observation period was 8 weeks. Patients in the DFPP group received DFPP twice. The evaluation included the Anti-Aging QOL Common Questionnaire (AAQol) and the blood vessel tests of Pulse wave velocity (PWV) and ankle-brachial index (ABI).Results: Among physical symptoms in AAQol, “tired eyes,” “blurry eyes,” “stiff shoulders,” and “feeling of ill-health” significantly decreased after 8 weeks in the DFPP group. Hematology revealed that hemoglobin (+3.6%, p=0.047), total protein (+4.1%, p=0.019), and albumin (+4.9%, p=0.018) were maintained at higher levels after 8 weeks in the DFPP group than the control group. Despite LDL-C removal, the hepatic steatosis index ALT (+5.7%, p=0.008) and lipid metabolism index LDL-C (+11.6%, p=0.012) were apparently higher in the DFPP group. Endocrinology showed a decreasing trend of DHEA-s (−13.7%, p=0.003), increasing trend of cortisol (+27.5%, p=0.005), and increasing trend of progesterone (+50%, p=0.030) in the DFPP group compared with the control group. High-sensitivity CRP tended to decrease in the DFPP group compared with the control group (−26.5%, p=0.030). There was no significant change in PWV or ABI in the DFPP group. No serious adverse events were caused by DFPP.Conclusion: LDL-C removal by DFPP might suppress inflammation and improve tissue environment in visceral adipose and liver tissues with fatty deposits.
No takes yet. Share an insight, caveat, or question.
Hibino et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: